Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency

著录项

• 来源
  《AIDS》 |2018年第11期|共7页
• 作者

  Evans Vanessa A.; van der Sluis Renee M.; Solomon Ajantha; Dantanarayana Ashanti; McNeil Catriona; Garsia Roger; Palmer Sarah; Fromentin Remi; Chomont Nicolas; Sekaly Rafick-Pierre; Cameron Paul U.; Lewin Sharon R.;

  展开▼
• 作者单位

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  Royal Prince Alfred Hosp Chris OBrien Lifehouse Melanoma Inst Australia Sydney NSW Australia;

  Royal Prince Alfred Hosp Dept Immunol Sydney NSW Australia;

  Westmead Millennium Inst Ctr Virus Res Sydney NSW Australia;

  Ctr Hosp Univ Montreal Ctr Rech Montreal PQ Canada;

  Ctr Hosp Univ Montreal Ctr Rech Montreal PQ Canada;

  Case Western Univ Cleveland OH USA;

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  Univ Melbourne Peter Doherty Inst Infect &

  Immun 792 Elizabeth St Melbourne Vic 3000 Australia;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 传染病;
• 关键词

  CD4-positive T-lymphocytes; HIV-1; ipilimumab; nivolumab; programmed cell death-1 receptor; pembrolizumab; virus latency;

  机译：CD4阳性T淋巴细胞;HIV-1;IPILIMIMAB;Nivolumab;编程的细胞死亡-1受体;PEMBROLIZUAB;病毒潜伏期;